TWST News and Press, Twist Bioscience Corporation From 06/05/24

Twist Bioscience Corporation (NASDAQ: TWST) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 11.58% on the day to $52.42. Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-bas...

2024-06-05 06:00:11 ET Subbu Nambi from Guggenheim issued a price target of $53.00 for TWST on 2024-06-05 04:57:00. The adjusted price target was set to $53.00. At the time of the announcement, TWST was trading at $46.98. The overall price target consensus is at $38.25 w...

Twist joins leading AI stakeholders to help advance the development and deployment of safe, trustworthy AI under new U.S. Government safety institute Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA...

2024-06-03 14:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

A look at the top 10 most actives in the United States AMC Entertainment Holdings Inc. Class A (AMC) rose 78.4% to $5.19 on volume of 478,215,489 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 32.3% to $0.061 on volume of 267,439,891 shares GameStop Corporation (GME) rose 74....

2024-05-13 14:35:46 ET More on Twist Bioscience Twist Bioscience: NGS Is Taking Off Twist Bioscience Corporation (TWST) Q2 2024 Earnings Call Transcript Twist Bioscience up 8% on 2024 revenue guidance raise, Q2 beats Twist Bioscience Q2 2024 Earnings Preview ...

No limit to number of fragments included in the pools Optimized chemistry enables direct synthesis of up to 500 bp double stranded fragments Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA usin...

2024-05-10 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Genomics is the future of medicine. With it, companies are racing to shed light on human health and disease. Over the last two decades, related studies have allowed us to create genetic risk sc...

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it h...

2024-05-03 13:32:54 ET Summary Market conditions remain tough for biotech companies, but Twist continues to perform well compared to peers. Twist Bioscience's second quarter results were strong, driven by NGS demand, and the company expects this strength to continue. Twist's v...